Fact checked by Nick Blackmer Semaglutide has been approved by the Food and Drug Administration (FDA) for type 2 diabetes ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will ...

The data could be useful as the federal government ponders Medicare coverage for GLP-1 weight loss drugs Savings were ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

GoodRx's latest research shows surging demand for weight loss medications like Wegovy and Zepbound, despite high costs and ...

Still, some patients struggle to access the drugs due to the spotty insurance coverage of weight loss treatments in the U.S. Without insurance or other savings, Zepbound and Wegovy both cost ...